Genmab A/S Adjusted Weighted Average Shares
Genmab A/S (GNMSF) reported Adjusted Weighted Average Shares of 62.69 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:AdjustedWeightedAverageShares · last filed 2026-02-17
| Period end | Adjusted Weighted Average Shares 12 month | Adjusted Weighted Average Shares 12 month as first filed |
|---|---|---|
| 2025-12-31 | 62.69M shares 20-F · filed 2026-02-17 | |
| 2024-12-31 | 64.66M shares 20-F · filed 2026-02-17 | 64.63M shares 6-K · filed 2025-02-12 |
| 2023-12-31 | 65.90M shares 20-F · filed 2026-02-17 | 65.91M shares 6-K · filed 2024-02-14 |
| 2022-12-31 | 66.01M shares 6-K · filed 2025-02-12 | |
| 2021-12-31 | 66.05M shares 6-K · filed 2024-02-14 | |
| 2020-12-31 | 65.89M shares 6-K · filed 2023-02-22 | |
| 2019-12-31 | 63.64M shares 6-K · filed 2022-02-16 | |
| 2018-12-31 | 62.04M shares 6-K · filed 2021-02-23 | |
| 2017-12-31 | 62.09M shares 20-F · filed 2020-03-30 |